GNPXInvestor•prnewswire•
Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Sentiment:Neutral (55)
Summary
(NASDAQ:GNPX) Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Sept. 2, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by prnewswire